NCTId,BriefTitle,OverallStatus,StudyType,Phases,Conditions,LeadSponsorName,StartDate,StudyFirstPostDate,LastUpdatePostDate,Timestamp
NCT02484560,Efficacy of Stem Cell Therapy in Ambulatory and Non-ambulatory Children With Duchenne Muscular Dystrophy - Phase 1-2,UNKNOWN,INTERVENTIONAL,PHASE1,Duchenne Muscular Dystrophy,University of Gaziantep,2015-06,2015-06-29,2015-07-01,2024-11-14T07:18:34.776724
NCT04906460,Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Wave Life Sciences Ltd.,2021-09-28,2021-05-28,2024-02-28,2024-11-14T07:18:34.776724
NCT00759876,Phase 2a Extension Study of Ataluren (PTC124) in Duchenne Muscular Dystrophy (DMD),TERMINATED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,PTC Therapeutics,2008-08-13,2008-09-25,2020-10-29,2024-11-14T07:18:34.776724
